Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01341483 · ClinicalTrials.gov registry record
Incidence of Male Pudendal Artery Stenosis in Suboptimal Erections Study
A clinical trial, sponsored by Medtronic Endovascular.
- Terminated
- Registry status
- 19
- Enrollment target
NCT01341483 is a clinical trial that was terminated before completion, run by Medtronic Endovascular. The registered enrollment target is 19 participants.
The verdict
NCT01341483 was terminated before completion, sponsored by Medtronic Endovascular.
- TERMINATED
- Registry status
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the proportion of men with known or suspected coronary artery disease (CAD) and/or peripheral arterial disease (PAD) that have angiographic identifiable erectile related artery (ERA) atherosclerotic disease defined as at least one ERA stenosis greater than or equal to 50% (per core lab Quantitative Vascular Analysis - QVA).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2011-04 |
| Est. Completion | 2012-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01341483
The ClinicalTrials.gov registry entry for NCT01341483 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Endovascular, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01341483 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01341483 about?
NCT01341483 is a clinical study titled "Incidence of Male Pudendal Artery Stenosis in Suboptimal Erections Study". The purpose of this study is to determine the proportion of men with known or suspected coronary artery disease (CAD) and/or peripheral arterial disease (PAD) that have angiographic identifiable erectile related artery (ERA) atherosclerotic disease defined as at least one ERA stenosis greater than o...
What is the current status of trial NCT01341483?
This trial is currently terminated. The enrollment target is 19 participants. The study started on 2011-04. Estimated completion is 2012-03.
Who is sponsoring clinical trial NCT01341483?
This trial is sponsored by Medtronic Endovascular, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.